Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03598270||Recruiting||Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)||
||Other / Industry||
||414||Female||18 Years and older (Adult, Older Adult)||NCT03598270||ANITA
|ANITA||November 21, 2018||May 2023||November 2023||July 25, 2018||February 4, 2019||